מונטהלוקאסט טבע ® 4 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

MONTELUKAST AS SODIUM 4 MG

Disponible desde:

TEVA PHARMACEUTICAL INDUST.LTD

Código ATC:

R03DC03

formulario farmacéutico:

CHEWABLE TABLETS

Vía de administración:

PER OS

Fabricado por:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupo terapéutico:

MONTELUKAST

indicaciones terapéuticas:

Montelukast Teva is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 2 to 5 years of age and older.

Fecha de autorización:

2010-06-01